Electrochemical Sensing of Anticancer Drug Using New Electrocatalytic Approach

Recent emerging trends in dendrimer research: Electrochemical sensors and their multifaceted applications in biomedical fields or healthcare

Dendrimers enhance the selectivity and sensitivity of sensors through their synthetic, highly branched, three-dimensional structures and large surface area. This unique architecture enables precise functionalization with various recognition elements, significantly improving the specificity and sensitivity of electrochemical sensors for detecting disease markers, biomolecules, and environmental pollutants. Dendrimer-based electrochemical sensors offer promising advancements in healthcare, such as detecting biomarkers for heart disease, monitoring blood glucose levels, and sensitively determining cancer-related proteins. Additionally, incorporating metals and conductive polymers into dendrimer nanocomposites can further enhance sensor performance. This review article provides a detailed overview of dendrimer's history, structure, properties, electrochemical properties, and synthesis methods. Particular attention has been paid to recent developments in the applications of dendrimers including electrochemical sensors, drug delivery, gene therapy and bioimaging. Recent progress in various applications of dendrimer-based electrochemical sensors developed over the last seven years, focusing on their healthcare applications and discussing the primary goals and challenges that will shape future research in this field, is also critically analyzed. These advances in dendrimer technology hold great potential for the development of novel therapeutics and expanded applications in sensor design.

Development of a molecularly imprinted electrochemical sensor for erlotinib detection using a modified screen-printed carbon electrode

A screen-printed carbon electrode (SPCE) based on a molecularly imprinted polymer (MIP) technique has been modified to provide detection of erlotinib (ERL). For this purpose, the pyrogallol (PG) monomer in the presence of ERL as an analyte has been electropolymerized on the SPCE surface. The introduced sensor has been characterized through differential pulse voltammetry (DPV), cyclic voltammetry (CV), and field emission scanning electron microscopy (FESEM) methods. The modified SPCE allowed ERL detection in a linear range of 0.05-800 nM with a limit of detection (LOD) of 0.016 nM. The applicability of modified SPCE was successfully investigated in serum samples. Lastly, for validation, sensor performance was compared with high-performance liquid chromatography (HPLC). The introduced sensor exhibited good application in the biomedical field.

Designing of ZnO nanoparticles oriented interface imprinted electrochemical sensor for fluoxetine detection

This study represents nanoparticle-based well-oriented recognition sites via interface imprinting, followed by selective and sensitive determination of fluoxetine (FLX). Herein, FLX was firstly immobilized onto ZnO NPs, and then polymerization was carried out with MAPA, HEMA, and EGDMA on the glassy carbon electrode via photopolymerization. After the etching of ZnO with and 10 mM HCI solution, a porous structure with recognition sites for FLX was constructed onto surface. The characterization of the electrochemical sensor was accomplished by utilizing CV, EIS, ATR-FTIR AFM, and SEM analysis. The DPV was used to determine FLX in standard solution, serum sample, and tap water. The effect of FLX concentration variation was studied using the DPV in the range of 1.0 × 10^-11 M to 1.0 × 10^-10 M with a detection limit of 2.67 × 10^-12 M. This sensor showed specific recognition toward template, and more than 90% of its original response was retained after being stored in the desiccator at R.T. for 5 days. This technique has proven to be a powerful, highly selective, and sensitive tool for the rapid detection of FLX in tap water and spike serum samples.